期刊文献+

饲喂重组鸡白细胞介素18蛋白增加肉仔鸡体重的初步研究 被引量:6

Efficacy of Recombinant Chicken Interleukine 18 Protein on Weight Gain for Broiler Chickens
下载PDF
导出
摘要 经口服途径给肉仔鸡饲喂重组鸡白细胞介素 1 8(ChIL -1 8)蛋白 ,观察其在正常饲养条件下和人工感染鸡传染性支气管炎病毒 (IBV)时对肉仔鸡的影响。将 84只肉仔鸡随机分为 2组 :正常称重组和IBV接种组。 2组肉仔鸡再随机各分为 3个亚组 ,分别每隔 5d各口服 1次PBS、细菌蛋白和重组ChIL -1 8蛋白。正常称重组每亚组 8只 ,每次口服前称重。IBV接种试验组每亚组 2 0只 ,在 30日龄时滴鼻接种IBVM41株并每隔 5d称重 1次。各亚组试验鸡分别在正压隔离器中饲养。结果表明 ,饲喂重组ChIL- 1 8蛋白的试验亚组肉仔鸡体重总增重量明显高于饲喂PBS和细菌蛋白的对照亚组 ;IBV接种试验组肉仔鸡在人工感染IBVM41株后 ,饲喂重组ChIL 1 8亚组的发病率和死亡率明显低于饲喂PBS和细菌蛋白亚组 ,而且后 2个亚组肉仔鸡临床症状也较饲喂重组ChIL- 1 8试验亚组明显。结果初步显示 ,饲喂重组ChIL -1 8融合蛋白能够增加肉仔鸡体重并可增强肉仔鸡对IBV感染的抵抗能力。 Eighty broiler chickens were used to evaluate the efficacy of recombinant ChIL 18 protein in vivo.Broilers were orally administrated with recombinant chicken Interleukine 18 (ChIL 18) protein expressed in E.coli,PBS and bacterial protein,respectively.Efficacy of the recombinant protein on broiler birds that reared under normal condition and IBV infection condition was investigated.As a result,the total weight gain of the birds administrated with ChIL 18 is obviously higher than those of administrating with PBS or bacterial protein.Furthermore,IBV infection trial suggested that orally administration with recombinant ChIL 18 to the IBV infected birds could enhance their growth performance and less susceptibility to IBV infection compared to non treated infected birds.The result study showed that recombinant chIL 18 protein can be absorbed in the digestive tract of the chickens and plays an important role in weight gain and resistance against IBV.
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2005年第3期60-64,共5页 China Biotechnology
基金 国家 8 63计划资助项目 (2 0 0 1AA2 490 3 2 )
关键词 肉仔鸡 饲喂 IBV 鸡体 接种试验 称重 人工感染 IL-18 正常 口服 Recombinant ChIL 18 Broiler Weight gain IBV
  • 相关文献

参考文献29

  • 1Wood P A. Chronotherapy of growth factors. J Infus Chemother,1995,5(1) :20 ~ 23.
  • 2Johnson C S. Modulation of chemotherapy antineoplastic agents with biologic agents:enhancement of antitumor activities by interleukin1. Curr Opin Oncol, 1992 ,4(6): 1108 ~ 1115.
  • 3Schulz G, Krumwieh D, Oster W. Adjuvant therapy with recombinant interleukin-3 and granulocyte-macrophage colonystimulating factor. Pharmacol Ther, 1991,52(1) :85 ~ 94.
  • 4Pasquini S, Xiang Z, Wang Y, et al. Cytokines and costimulatory molecules as genetic adjuvants. Immunol Cell Biol, 1997,75 (4):397 ~ 401.
  • 5Asadullah K, Sabat R, Friedrich M, et al. Interleukin-10: an important immunoregulatory cytokine with major impact on psoriasis. Curr Drug Targets Inflamm Allergy, 2004, 3 (2):185 ~192.
  • 6Greenwood V, Meerveld B, Tyler K, et al. Recombinant human interleukin-11 modulates ion transport and mucosal inflammation in the small intestine and colon. Lab Invest, 2000,80 ( 8 ): 1269 ~1280.
  • 7Armitage R J, Macduff B M, Eisenman J, et al. IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J Immunol, 1995,154(2) :483 ~ 490.
  • 8Kohyama M, Saijyo K, Hayasida M, et al. Direct activation of human CD8^+ cytotoxic T lymphocytes by interleukin-18. Jpn J Cancer Res, 1998,89(10): 1041 ~ 1046.
  • 9Okamura H, Tsutsui H, Komatsu T, et al. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature, 1995,378: 88 ~91.
  • 10Fantuzzi G, Puren A J, Harding M W, et al. Interleukin-18regulation of interferon gamma production and cell proliferation as shown in interleukin-1 beta-converting enzyme (Caspase-1)deficient mice. Blood, 1998,91:2118 ~ 2125.

二级参考文献17

  • 1Okamura H, Tsutsui H, Komatsu T, et al. Cloning of a new cytokine that induces IFN-γproduction by T cells[J]. Nature,1995,378:88-91.
  • 2Ushio S, Namba M, Okura T, et al. Cloning of the cDNA for human IFN- gamma-inducing factor, expression in Escherichia coil, and studies on the biologic activities of the protein[J]. J Immunol,1996, 156:4 274-4 279.
  • 3Kikuchi T, Akasaki Y, Joki T, et aL Antitumor activity of interleukin-18 on mous glioma cells[J]. J Immunotherapy, 2000,23(2): 184-189.
  • 4Yoshimoto T, Nagai N, Ohkusu K, et al. LPS-stimulated SJL macrophages produce IL-12 and IL-18 that inhibit IgE production from CD3intIL 2R beta + T cells[J].J Immunol ,1998, 161(3): 1 483-1492.
  • 5Rothe H, Jenkins N A, Copeland N G, et al. Active of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near Idd2[J]. J Clin Invest, 1997,99:469-453.
  • 6Gracie J A, Forsey R J, Chan W L, et al. A proinflammatory role for IL-18 in rheumatoid arthritis[J]. J Clin Invest, 1999, 104(10): 1 393-1 041.
  • 7Schneider K, Puehler F, Baeubrle D, et al. cDNA cloning of biologiealiy active chicken interleukin-18[J]. J Interferon Cytokine Res,2000, 20: 879-883.
  • 8Bazan J F, Timans J C, Kastelein R A. A newly defined interleukin-1? [J]. Nature,1996,379:591.
  • 9Kohno K, Kurimoto M. Interleukin-18, a cytokine which resembles IL-1 structurally and IL-12 functionally but exerts its effect independently of both[J]. Clin Immunol Immunopath,1998,86(1):11-15.
  • 10Gu Y, Kuida K, Tsutsui H, et al. Activation of interferon-gamma-inducing factor mediated by interleukin-1βconverting enzyme[J]. Science, 1997, 275 : 206-209.

共引文献10

同被引文献96

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部